Transamerica Financial Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$709K Buy
14,711
+5,245
+55% +$245K 0.06% 251
2025
Q4
$459K Buy
9,466
+1,460
+18% +$72.4K 0.04% 273
2025
Q3
$378K Buy
8,006
+2,384
+42% +$115K 0.03% 259
2025
Q2
$272K Buy
5,622
+531
+10% +$27.1K 0.03% 202
2025
Q1
$283K Sell
5,091
-656
-11% -$35.5K 0.03% 207
2024
Q4
$278K Buy
5,747
+987
+21% +$50.2K 0.03% 205
2024
Q3
$275K Buy
+4,760
New +$257K 0.03% 208
2017
Q1
Sell
-64
Closed -$3K 429
2016
Q4
$3K Buy
+64
New +$2.52K ﹤0.01% 286

Other funds holding SNY

Transamerica Financial Advisors's SNY Position: Q1 2026 in Review

Transamerica Financial Advisors increased its Sanofi (SNY) stake by 55% in Q1 2026, buying an estimated $245K and bringing the position to 14,711 shares worth $709K. The position accounts for 0.06% of the portfolio, ranked #251.

Transamerica Financial Advisors first reported a position in SNY in Q4 2016 and has held it in 8 quarters since. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Transamerica Financial Advisors held 14,711 shares of Sanofi worth $709K as of Q1 2026.
  • Transamerica Financial Advisors bought 5,245 Sanofi shares in Q1 2026, an estimated $245K.
  • Sanofi made up 0.06% of Transamerica Financial Advisors's portfolio in Q1 2026, its #251 holding.
  • Transamerica Financial Advisors first reported a position in Sanofi in Q4 2016 and has held it in 8 quarters since.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Transamerica Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.